Browsing Tag
NASDAQ
801 posts
NYSE parent ICE to acquire bond-trading platform MarketAxess in $6bn cash deal
ICE will pay $167 in cash for MarketAxess, a 33% premium and 10.6x synergized EBITDA, but MKTX was already losing share to Tradeweb before the offer landed.
Meta Q2 2026: Revenue jumps 28% to $60.8bn but margins slide on AI costs
Meta Q2 revenue surges 28% to $60.8B and ad prices climb 12%, but operating margin falls to 31% as record capex and a $2.4B legal charge weigh on EPS.
SkinJect trial clearance gives Medicus Pharma a regulatory win as Nasdaq pressure builds
Medicus Pharma gains FDA clearance for its SkinJect Gorlin syndrome trial as stricter endpoints, secured debt and Nasdaq risks shape the outlook.
Why Capstone Energy+’s Scripps Mercy project matters more than its 2 MW capacity suggests
The Scripps Mercy Hospital installation gives Capstone Energy+ a high-value healthcare reference, but commissioning, verified economics and repeat orders will determine its commercial significance.
ATEC remains 63% below its 52-week high, can Alphatec Holdings’ surgical growth revive sentiment?
Alphatec Holdings, Inc. is preparing for a series of investor meetings that could sharpen market attention on its growth strategy, margin expansion and ability to convert rising spine-surgery volumes into sustainable cash generation.
Neuphoria Therapeutics shares jumped while Scancell plunged, and the merger terms explain why
Scancell’s Neuphoria Therapeutics merger unlocks Nasdaq access and up to $89 million, but dilution and debt reshape the iSCIB1+ outlook.
Rigetti Computing deepens HPE and Pittsburgh Supercomputing Center partnership with NSF-backed TangleLab quantum testbed
Rigetti anchors NSF-funded TangleLab with HPE and PSC, but the 2027 build-out and Cepheus commercial traction will decide the rerating case.
SS&C Technologies (NASDAQ: SSNC) jumps 10% as organic growth accelerates
SS&C Technologies stock jumped 10% as organic growth accelerated. Can automation, cash flow and buybacks support the SSNC valuation?
Almonty Industries to leave ASX and TSX as Nasdaq becomes centre of tungsten growth strategy
Almonty Industries is withdrawing from the Australian Securities Exchange and Toronto Stock Exchange as trading liquidity and capital increasingly concentrate on Nasdaq. The move simplifies its public-market structure, but Australian CDI holders must decide whether to convert, sell or enter a post-delisting sale facility.
Eastern Bankshares (EBC) posts record operating income of $106.5m, lifts wealth assets to $11.5bn
Eastern Bankshares posts record $106.5M operating income and a 5% buyback authorization, but CRE payoffs and rising deposit costs test the growth thesis.